- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms
Total 3767 results
-
Unity Health TorontoCompletedOveractive BladderCanada
-
Prof. Dr. med. Marc PossoverUnknownBladder, OveractiveSwitzerland
-
Lawson Health Research InstituteCompleted
-
Stéphane BolducPfizerCompleted
-
Assiut UniversityUnknown
-
MedtronicNeuroCompletedOveractive BladderUnited States
-
PfizerCompleted
-
University of Alabama at BirminghamPfizerCompleted
-
Weill Medical College of Cornell UniversityNaturex-DbsCompletedOveractive BladderUnited States
-
Weill Medical College of Cornell UniversityLaborie Medical Technologies Inc.; Urodynamix TechnologiesCompleted
-
Lanzhou Institute of Biological Products Co., LtdUnknown
-
University of Alabama at BirminghamCompletedOveractive Bladder | Lower Urinary Tract SymptomsUnited States
-
Buddhist Tzu Chi General HospitalCompleted
-
SK Chemicals Co., Ltd.CompletedOveractive BladderKorea, Republic of
-
Kenneth Peters, MDCompletedOveractive BladderUnited States
-
Astellas Pharma IncCompleted
-
Hanmi Pharmaceutical Company LimitedCompleted
-
Laborie Medical Technologies Inc.TerminatedOveractive Bladder | Lower Urinary Tract SymptomsUnited States, Canada, United Kingdom
-
Cantonal Hospital, FrauenfeldAstellas Pharma IncCompleted
-
UroGen Pharma Ltd.TerminatedOveractive BladderIsrael
-
AllerganCompletedOveractive BladderUnited States
-
KYU-SUNG LEEAstellas Pharma Korea, Inc.CompletedOveractive BladderKorea, Republic of
-
AllerganCompletedOveractive BladderUnited Kingdom, Belgium, New Zealand, France, Russian Federation, Czech Republic, United States, Germany, Austria, Poland, Slovakia, Ukraine, Canada, Australia
-
Astellas Pharma IncCompleted
-
University of AarhusCompleted
-
Miami VA Healthcare SystemPfizerCompletedOveractive BladderUnited States
-
AllerganTerminatedOveractive BladderUnited States, Canada, India, Australia
-
National Taiwan University HospitalTerminated
-
LG Life SciencesKyorin Pharmaceutical Co.,LtdCompletedOveractive BladderKorea, Republic of
-
University of ZurichCompleted
-
Astellas Pharma IncAstellas Pharma China, Inc.CompletedOveractive BladderChina
-
EMKinetics, IncCompletedOveractive BladderUnited States
-
University of California, IrvineCompletedOveractive BladderUnited States
-
PfizerCompletedOveractive BladderCzech Republic, Slovakia, United Kingdom, Sweden, Norway, Lithuania
-
Università degli Studi dell'InsubriaCompletedDetrusor OveractivityItaly
-
Samsung Medical CenterCompletedOveractive BladderKorea, Republic of
-
GlaxoSmithKlineCompletedOveractive BladderUnited States
-
Università degli Studi dell'InsubriaCompletedOveractive BladderItaly
-
William Beaumont HospitalsCompleted
-
Novartis PharmaceuticalsCompletedProstate Cancer With at Least One Bone Lesion in Patients Receiving Hormonal Therapy and Treatment With Bisphosphonates is Indicated
-
Merck Sharp & Dohme LLCTerminatedOveractive Bladder | Overactive Urinary Bladder
-
Mereo BioPharmaNovartisTerminatedPelvic Pain Associated With Refractory EndometriosisUnited States, Puerto Rico
-
Laval UniversityJohnson & Johnson; Centre de Recherche de l'Institut Universitaire de Cardiologie...UnknownGastrectomy | Microalbuminuria | Biliopancreatic Diversion With Duodenal SwitchCanada
-
Nymox CorporationCompletedPhase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)Benign Prostatic Hyperplasia (BPH) | Enlarged ProstateUnited States
-
Medice Arzneimittel Pütter GmbH & Co KGDr. Wiedey GmbH - Institut Für Klinische Forschung; Medidata Dr. Möller GmbHCompletedUrinary Tract Infection Lower Acute
-
Thai Red Cross AIDS Research CentreRecruitingMen Who Have Sex With Men and Transgender WomenThailand
-
AZ St.-Dimpna GeelCompletedAnastomosis, Roux-en-Y | Surgical Operation With Anastomosis, Bypass or Graft
-
A. Vogel AGUniversity of LondonUnknownSexual Dysfunctions in Men With Benign Prostatic HyperplasiaSwitzerland
-
Astellas Pharma Europe B.V.CompletedNeurogenic Detrusor OveractivityUnited States, Belgium, Brazil, Denmark, Hungary, Korea, Republic of, Mexico, Philippines, Poland, Turkey